1. Epigenetic strategies synergize with PD-L1/PD-1 targeted cancer immunotherapies to enhance antitumor responses
   Xi Chen et al, 2020, Acta Pharmaceutica Sinica B CrossRef
2. Cause and Consequence of Cancer/Testis Antigen Activation in Cancer
   Angelique W. Whitehurst, 2014, Annual Review of Pharmacology and Toxicology CrossRef
3. Decitabine: a promising epi-immunotherapeutic agent in solid tumors
   Xiang Li et al, 2015, Expert Review of Clinical Immunology CrossRef
4. Construction of random tumor transcriptome expression library for creating and selecting novel tumor antigens
   Huizhun Zhao et al, 2016, Tumor Biology CrossRef
5. Diagnostic Bioliquid Markers for Pancreatic Cancer: What We Have vs. What We Need
   Geou-Yarh Liou et al, 2023, Cancers CrossRef
6. Understanding the epigenetic regulation of tumours and their microenvironments: opportunities and problems for epigenetic therapy
   Man Liu et al, 2017, The Journal of Pathology CrossRef
7. An Ovarian Cancer Susceptible Gene Prediction Method Based on Deep Learning Methods
   Lu Ye et al, 2021, Frontiers in Cell and Developmental Biology CrossRef
8. Targeting Tumor Initiating Cells through Inhibition of Cancer Testis Antigens and Notch Signaling: A Hypothesis
   Michela Colombo et al, 2015, International Reviews of Immunology CrossRef